SCHEMBL17166368

SCHEMBL17166368

Cc1cnc(N[C@H]2CCC[C@@H]2NC(=O)c2ccccc2-c2nc(C)no2)cn1

nearest known ligand 0.80

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 19/20 0.80
HCRTR2 O43614 2/20 0.60
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17017373 1.00 HCRTR1 (0.80) HCRTR1HCRTR2POLB
SCHEMBL17017366 0.90 HCRTR1 (0.78) HCRTR1HCRTR2
SCHEMBL17007307 0.89 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL17021456 0.89 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL17166372 0.87 HCRTR1 (0.83) HCRTR1HCRTR2
SCHEMBL17017374 0.87 HCRTR1 (0.83) HCRTR1HCRTR2
SCHEMBL22131252 0.86 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL17007102 0.86 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL17028118 0.86 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL16666165 0.85 HCRTR1 (0.67) HCRTR1HCRTR2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9156829-B2 Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-10-13 US disclosed